Pheton Holdings Ltd Announces Corporate Name Change and Stock Ticker Symbol Change
Rhea-AI Summary
Pheton Holdings Ltd (PTHL) announced on January 13, 2026 that it will change its corporate name to iTonic Holdings Ltd and its Nasdaq ticker symbol from PTHL to ITOC. The company said the changes reflect its new business strategy and future development plans. The Corporate Events are expected to become effective upon the commencement of trading on the Nasdaq Capital Market on January 16, 2026 (U.S. Eastern Time), at which time the company’s Class A ordinary shares will cease trading under PTHL and begin trading under ITOC.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, PTHL declined 4.40%, reflecting a moderate negative market reaction. Argus tracked a peak move of +15.6% during that session. Argus tracked a trough of -4.3% from its starting point during tracking. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $369K from the company's valuation, bringing the market cap to $8M at that time.
Data tracked by StockTitan Argus on the day of publication.
Market Reality Check
Peers on Argus
PTHL fell 6.1% while only one momentum peer, INBS, was flagged, moving down. Other sector peers showed mixed moves, indicating today’s action looks more stock-specific than sector-driven.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 05 | Strategic acquisition | Positive | -0.5% | Closed 51% acquisition of iTonic Corporation, expanding into U.S. home health AI. |
| Oct 23 | Listing compliance notice | Negative | -1.9% | Nasdaq minimum bid price deficiency notice and 180-day compliance window disclosure. |
| Aug 01 | Market-rumor response | Negative | -8.9% | Company rebutted manipulation and M&A rumors after sharp decline post short report. |
Recent news events, whether positive (acquisition) or negative (Nasdaq notice, rumor response), were followed by modest-to-sharp declines, suggesting a tendency for selling into headlines.
Over the past six months, Pheton reported several notable events. On Aug 01, 2025, it addressed market volatility and rumors, yet shares fell 8.95%. A Nasdaq minimum bid price deficiency notice on Oct 23, 2025 led to a 1.88% decline. The 51% acquisition of iTonic Corporation, closed on Nov 25, 2025 and announced Dec 5, saw a 0.53% drop. Today’s name and ticker change to iTonic Holdings Ltd connects directly to that acquisition strategy.
Market Pulse Summary
This announcement formalized the transition from Pheton Holdings Ltd to iTonic Holdings Ltd and the ticker change from “PTHL” to “ITOC,” effective January 16, 2026. The move ties directly to the earlier acquisition of iTonic Corporation and signals a sharper focus on that platform. Investors may track progress against this new strategy, Nasdaq bid-price compliance milestones, and subsequent filings or operational updates to gauge how effectively the rebrand translates into business traction.
Key Terms
brachytherapy medical
nasdaq capital market regulatory
AI-generated analysis. Not financial advice.
BEIJING, China, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the “Company” or “Pheton”), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, announced today that it will change its corporate name to iTonic Holdings Ltd, and change its stock ticker symbol to "ITOC" (collectively, the "Corporate Events"). The Company anticipates that the Corporate Events will be effective upon the commencement of trading on the Nasdaq Capital Market on January 16, 2026 (U.S. Eastern Time), at which time the Company’s Class A ordinary shares will cease trading under the current ticker symbol "PTHL" and will begin trading under the new ticker symbol "ITOC" on the Nasdaq Capital Market. The corporate name change and stock ticker symbol change reflects the Company's new business strategy and its future development plans.
About Pheton Holdings Ltd
Founded in 1998, Pheton Holdings Ltd, through its wholly owned operating subsidiary, Beijing Feitian Zhaoye Technology Co., Ltd., focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its lead product, Beijing Feitian’s Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors. Pheton Holdings is committed to leveraging its products and services to establish a potential new standard of care across multiple malignant tumor applications. For more information, please visit: http://www.ftzy.com.cn/ir.
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995, including but not limited to statements related to Pheton’s cash position, financial resources and potential for future growth, market acceptance and penetration of new or planned product offerings, and future recurring revenues and results of operations. These forward-looking statements can be identified by terminology such as “aim,” “anticipate,” “believe,” “estimate,” “expect,” “hope,” “going forward,” “intend,” “ought to,” “plan,” “project,” “potential,” “seek,” “may,” “might,” “can,” “could,” “will,” “would,” “shall,” “should,” “is likely to” and the negative form of these words and other similar expressions. Among other things, statements that are not historical facts, including statements about the Company’s beliefs and expectations are or contain forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement. All information provided in this press release is as of the date of this press release and is based on assumptions that the Company believes to be reasonable as of this date, and the Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
For investor and media inquiries, please contact:
Pheton Holdings Ltd
Investor Relations
Email: ir@ftzy.com.cn
Lambert by LLYC
Jackson Lin
Phone: +1-646-717-4593
Email: jian.lin@llyc.global
FAQ
When will Pheton Holdings (PTHL) change its name to iTonic Holdings Ltd?
What is the new Nasdaq ticker symbol for Pheton Holdings (PTHL)?
Will Pheton’s Class A ordinary shares stop trading under PTHL on Nasdaq?
Why is Pheton Holdings changing its corporate name and ticker to iTonic (ITOC)?
Which market will iTonic Holdings Ltd (ITOC) trade on after the change?
Does the announcement indicate any change to the company’s share class or capital structure?
